Durvalumab vs Sildenafil

Durvalumab vs Sildenafil: Overview

This comparison examines the pharmacological differences between Durvalumab and Sildenafil.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Sildenafil: Selective PDE5 inhibitor increasing cGMP.

Pharmacokinetics

Half-life: Durvalumab — 17 days; Sildenafil — 4 hours.

Chemical Properties

Molecular Formula: Sildenafil — C22H30N6O4S.

Molecular Weight: Sildenafil — 474.5800 g/mol.

Type: Durvalumab — Antibody; Sildenafil — Small molecule.